Evaxion Biotech A/S
EVAX2.660USD
+0.050+1.92%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
37.31MMarket Cap
LossP/E TTM
Evaxion Biotech A/S
2.660
+0.050+1.92%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q1
FY2019Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
30.69%-5.19M
-102.87%-8.19M
6.33%-4.12M
---6.29M
---7.49M
-36.78%-4.04M
-98.42%-4.39M
---2.95M
---2.21M
Net income from continuing operations
30.08%-4.77M
-41.49%-5.79M
-96.29%-8.37M
---5.25M
---6.82M
-32.07%-4.09M
-21.17%-4.26M
---3.10M
---3.52M
Operating gains losses
----
----
----
----
----
----
-3.33%29.00K
----
--30.00K
Other non-cash items
-1271.43%-820.00K
86.81%-129.00K
484.26%1.59M
---138.00K
--70.00K
-292.90%-978.00K
-311.79%-413.00K
--507.00K
--195.00K
Change in working capital
157.86%427.00K
-308.96%-2.17M
1952.67%2.69M
---906.00K
---738.00K
389.94%1.04M
-81.34%131.00K
---358.00K
--702.00K
-Change in receivables
----
----
--846.00K
----
----
----
-100.00%0.00
----
--688.00K
-Change in other current assets
----
----
----
----
----
----
--20.00K
----
--0.00
Cash from non-recurring investing activities
Cash from operating activities
30.69%-5.19M
-102.87%-8.19M
6.33%-4.12M
---6.29M
---7.49M
-36.78%-4.04M
-98.42%-4.39M
---2.95M
---2.21M
Investing cash flow
Net cash from continuing investing activities
-83.73%83.00K
-47.08%181.00K
144.44%176.00K
--332.00K
--510.00K
434.38%342.00K
53.19%72.00K
--64.00K
--47.00K
Capital expenditures
-83.73%83.00K
-47.08%181.00K
144.44%176.00K
--332.00K
--510.00K
434.38%342.00K
53.19%72.00K
--64.00K
--47.00K
Net cash flow from disposal of fixed assets
-83.73%83.00K
-35.82%181.00K
144.44%176.00K
--332.00K
--510.00K
340.63%282.00K
53.19%72.00K
--64.00K
--47.00K
Net cash flow from intangible asset transactions
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--60.00K
--0.00
----
----
Net cash flow from other investing activities
-60.00%6.00K
46.67%22.00K
99.52%-1.00K
--1.00K
--15.00K
188.24%15.00K
---209.00K
---17.00K
----
Cash from non-current investing activities
Net cash flow from investing activities
84.44%-77.00K
51.38%-159.00K
37.01%-177.00K
---331.00K
---495.00K
-303.70%-327.00K
-497.87%-281.00K
---81.00K
---47.00K
Financing cash flow
Cash flow from continuous financing activities
-757.14%-300.00K
-69.36%7.74M
938.46%24.65M
---65.00K
---35.00K
140388.89%25.25M
872.95%2.37M
---18.00K
--244.00K
Net cash flow from debt Issuance/repayment
-205.71%-107.00K
18095.35%7.74M
-620.00%-144.00K
---67.00K
---35.00K
-138.89%-43.00K
-11.11%-20.00K
---18.00K
---18.00K
Net cash flow from common stock issuance/repurchase
--28.00K
-100.00%0.00
984.09%25.95M
--1.00K
--0.00
--27.90M
137.97%2.39M
----
--1.01M
Net cash flow from other financing activities
---221.00K
100.00%0.00
---1.16M
--1.00K
--0.00
---2.60M
100.00%0.00
----
---744.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
-757.14%-300.00K
-69.36%7.74M
938.46%24.65M
---65.00K
---35.00K
140388.89%25.25M
872.95%2.37M
---18.00K
--244.00K
Net cash flow
Beginning cash balance
16.52%31.41M
451.35%32.17M
51.65%11.94M
--18.80M
--26.95M
-38.97%5.83M
-31.34%7.88M
--9.56M
--11.47M
Current period cash flow changes
24.51%-6.16M
-103.58%-757.00K
1090.30%20.22M
---6.86M
---8.16M
757.16%21.12M
-6.80%-2.04M
---3.21M
---1.91M
Effect of exchange rate changes
-327.54%-590.00K
-164.94%-150.00K
-153.88%-139.00K
---164.00K
---138.00K
240.00%231.00K
145.71%258.00K
---165.00K
--105.00K
Ending cash balance
34.33%25.25M
16.52%31.41M
451.35%32.17M
--11.94M
--18.80M
324.82%26.95M
-38.97%5.83M
--6.34M
--9.56M
Free cash flow
34.07%-5.27M
-91.16%-8.37M
3.90%-4.29M
---6.63M
---8.00M
-45.22%-4.38M
-97.48%-4.46M
---3.01M
---2.26M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
